The World's Greatest Investing Community
Results 1 - 10 of 12919 : 1 2 3 4 5 6 7 8 9 Next
3 Health-Care Stocks Crushing the Market
May gains have investors smiling.
Chelsea gets updated information from the FDA.
That's what phase 2 trials are for.
Are 3 Failed Phase 3 Trials Enough?
The NExUS between ESCAPE and MISSION is failure.
Has Sohu.com Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
This Just In: More Upgrades and Downgrades
New ratings for DryShips, Linn Energy, and Aastrom BioSciences.
Too Little, Too Late for Achillion?
Achillion produces solid hepatitis C data, but competitors are out in front.
This options strategy could be profitable if the FDA delays its decision.
Competitors have it down, but not out.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK